Research & Development Expenses
The latest quarterly r&d expense is $9.17 Million with a quarter-over-quarter change of -24.72%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
ALB R&D Expense
Reported quarterly R&D expense; no daily interpolation.
Current R&D Expense
$9.17M
$9.17 Million
Quarter-over-Quarter Change
-24.72%
vs. $12.18M prior quarter
Historical Data
96
Quarters of data available
Quarterly R&D Expense History
| Period | R&D Expense | QoQ Change | % Change |
|---|---|---|---|
| Q1 2026 | $9.17M | $-3.01M | -24.72% |
| Q4 2025 | $12.18M | $-493,000 | -3.89% |
| Q3 2025 | $12.67M | +$230,000 | +1.85% |
| Q2 2025 | $12.44M | $-1.66M | -11.74% |
| Q1 2025 | $14.10M | $-5.92M | -29.58% |
| Q4 2024 | $20.02M | $-2.38M | -10.61% |
| Q3 2024 | $22.40M | +$1.63M | +7.83% |
| Q2 2024 | $20.77M | $-2.76M | -11.74% |
| Q1 2024 | $23.53M | +$779,000 | +3.42% |
| Q4 2023 | $22.75M | +$1.67M | +7.93% |
| Q3 2023 | $21.08M | $-337,000 | -1.57% |
| Q2 2023 | $21.42M | +$948,000 | +4.63% |
| Q1 2023 | $20.47M | +$317,000 | +1.57% |
| Q4 2022 | $20.15M | +$1.80M | +9.78% |
| Q3 2022 | $18.36M | +$972,000 | +5.59% |
| Q2 2022 | $17.39M | +$1.30M | +8.10% |
| Q1 2022 | $16.08M | +$3.96M | +32.64% |
| Q4 2021 | $12.13M | $-1.16M | -8.76% |
| Q3 2021 | $13.29M | $-687,000 | -4.92% |
| Q2 2021 | $13.98M | $-660,000 | -4.51% |
| Q1 2021 | $14.64M | $-739,000 | -4.81% |
| Q4 2020 | $15.38M | +$1.84M | +13.62% |
| Q3 2020 | $13.53M | $-678,000 | -4.77% |
| Q2 2020 | $14.21M | $-1.89M | -11.72% |
| Q1 2020 | $16.10M | +$1.83M | +12.86% |
| Q4 2019 | $14.26M | $-1.32M | -8.48% |
| Q3 2019 | $15.59M | +$2.12M | +15.77% |
| Q2 2019 | $13.46M | $-1.51M | -10.12% |
| Q1 2019 | $14.98M | $-1.41M | -8.59% |
| Q4 2018 | $16.38M | $-226,000 | -1.36% |
| Q3 2018 | $16.61M | +$536,000 | +3.33% |
| Q2 2018 | $16.07M | $-4.91M | -23.41% |
| Q1 2018 | $20.99M | +$79,000 | +0.38% |
| Q4 2017 | $20.91M | $-856,000 | -3.93% |
| Q3 2017 | $21.76M | +$4.43M | +25.53% |
| Q2 2017 | $17.34M | $-6.99M | -28.72% |
| Q1 2017 | $24.32M | +$5.23M | +27.41% |
| Q4 2016 | $19.09M | $-1.92M | -9.14% |
| Q3 2016 | $21.01M | +$512,000 | +2.50% |
| Q2 2016 | $20.50M | +$628,000 | +3.16% |
| Q1 2016 | $19.87M | $-5.88M | -22.82% |
| Q4 2015 | $25.75M | +$3.85M | +17.55% |
| Q3 2015 | $21.90M | $-22,000 | -0.10% |
| Q2 2015 | $21.93M | $-4.57M | -17.24% |
| Q1 2015 | $26.49M | +$5.10M | +23.83% |
| Q4 2014 | $21.39M | $-1.01M | -4.52% |
| Q3 2014 | $22.41M | +$470,000 | +2.14% |
| Q2 2014 | $21.94M | $-635,000 | -2.81% |
| Q1 2014 | $22.57M | +$1.28M | +6.04% |
| Q4 2013 | $21.29M | +$1.85M | +9.50% |
| Q3 2013 | $19.44M | $-2.12M | -9.85% |
| Q2 2013 | $21.57M | +$1.61M | +8.08% |
| Q1 2013 | $19.95M | +$825,000 | +4.31% |
| Q4 2012 | $19.13M | $-703,000 | -3.54% |
| Q3 2012 | $19.83M | $-1.08M | -5.16% |
| Q2 2012 | $20.91M | +$1.86M | +9.77% |
| Q1 2012 | $19.05M | +$62,000 | +0.33% |
| Q4 2011 | $18.99M | $-1.55M | -7.53% |
| Q3 2011 | $20.53M | +$587,000 | +2.94% |
| Q2 2011 | $19.95M | +$2.33M | +13.24% |
| Q1 2011 | $17.61M | +$2.94M | +20.06% |
| Q4 2010 | $14.67M | +$336,000 | +2.34% |
| Q3 2010 | $14.34M | $-331,000 | -2.26% |
| Q2 2010 | $14.67M | $-52,000 | -0.35% |
| Q1 2010 | $14.72M | $-118,000 | -0.80% |
| Q4 2009 | $14.84M | $-146,000 | -0.97% |
| Q3 2009 | $14.98M | +$30,000 | +0.20% |
| Q2 2009 | $14.95M | $-1.19M | -7.38% |
| Q1 2009 | $16.14M | +$638,000 | +4.11% |
| Q4 2008 | $15.51M | $-1.89M | -10.84% |
| Q3 2008 | $17.39M | $-201,000 | -1.14% |
| Q2 2008 | $17.59M | +$793,000 | +4.72% |
| Q1 2008 | $16.80M | +$166,000 | +1.00% |
| Q4 2007 | $16.63M | +$1.21M | +7.86% |
| Q3 2007 | $15.42M | +$498,000 | +3.34% |
| Q2 2007 | $14.92M | $-787,000 | -5.01% |
| Q1 2007 | $15.71M | +$3.60M | +29.77% |
| Q4 2006 | $12.11M | +$558,000 | +4.83% |
| Q3 2006 | $11.55M | +$351,000 | +3.13% |
| Q2 2006 | $11.20M | $-247,000 | -2.16% |
| Q1 2006 | $11.45M | +$1.20M | +11.70% |
| Q4 2005 | $10.25M | +$139,000 | +1.38% |
| Q3 2005 | $10.11M | $-235,000 | -2.27% |
| Q2 2005 | $10.34M | $-638,000 | -5.81% |
| Q1 2005 | $10.98M | $-1.52M | -12.20% |
| Q4 2004 | $12.51M | +$3.40M | +37.40% |
| Q3 2004 | $9.10M | +$4.01M | +78.87% |
| Q2 2004 | $5.09M | +$509,000 | +11.12% |
| Q1 2004 | $4.58M | +$301,000 | +7.04% |
| Q4 2003 | $4.28M | $-492,000 | -10.31% |
| Q3 2003 | $4.77M | +$349,000 | +7.89% |
| Q2 2003 | $4.42M | $-521,000 | -10.54% |
| Q1 2003 | $4.94M | +$1.37M | +38.47% |
| Q4 2002 | $3.57M | $-551,000 | -13.37% |
| Q3 2002 | $4.12M | +$100,000 | +2.49% |
| Q2 2002 | $4.02M | — | — |
About Albemarle Corporation
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Jerry Kent Jr.